Melatonin pharmacological blood levels increase total antioxidant capacity in critically ill patients

Giovanni Mistraletti, Rita Paroni, Michele Umbrello, Lara D’Amato, Giovanni Sabbatini, Martina Taverna, Paolo Formenti, Elena Finati, Gaia Favero, Francesca Bonomini, Rita Rezzani, Russel J Reiter, Gaetano Iapichino

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In this study, the aim was to test the biochemical effects of melatonin supplementation in Intensive Care Unit (ICU) patients, since their blood levels are decreased. Sixty-four patients were enrolled in the study. From the evening of the 3rd ICU day, patients were randomized to receive oral melatonin (3 mg, group M) or placebo (group P) twice daily, at 20:00 and 24:00, until discharged. Blood was taken (at 00:00 and 14:00), on the 3rd ICU day to assess basal nocturnal melatonin values, and then during the treatment period on the 4th and 8th ICU days. Melatonin, total antioxidant capacity, and oxidative stress were evaluated in serum. Melatonin circadian rhythm before treatment was similar in the two groups, with a partial preservation of the cycle. Four hours from the 1st administration (4th ICU day, 00:00), melatonin levels increased to 2514 (982.3; 7148) pg·mL−1 in group M vs. 20.3 (14.7; 62.3) pg·mL−1 in group P (p < 0.001). After five treatment days (8th ICU day), melatonin absorption showed a repetitive trend in group M, while in group P nocturnal secretion (00:00) was impaired: 20 (11.5; 34.5) pg·mL−1 vs. 33.8 (25.0; 62.2) on the 3rd day (p = 0.029). Immediately from the beginning of treatment, the total antioxidant capacity was significantly higher in melatonin treated subjects at 00:00; a significant correlation was found between total antioxidant capacity and blood melatonin values (ρ = 0.328; p < 0.001). The proposed enteral administration protocol was adequate, even in the early phase, to enhance melatonin blood levels and to protect the patients from oxidative stress. The antioxidant effect of melatonin could play a meaningful role in the care and well-being of these patients.

Original languageEnglish (US)
Article number759
JournalInternational Journal of Molecular Sciences
Volume18
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

melatonin
antioxidants
Melatonin
Antioxidants
Critical Illness
blood
Blood
Pharmacology
Intensive care units
Intensive Care Units
Oxidative stress
Oxidative Stress
circadian rhythms
secretions
evening
Therapeutics
Circadian Rhythm
serums
Small Intestine

Keywords

  • Antioxidants
  • Critical illness
  • Dietary supplements
  • Melatonin
  • Oxidative stress

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Computer Science Applications
  • Spectroscopy
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Mistraletti, G., Paroni, R., Umbrello, M., D’Amato, L., Sabbatini, G., Taverna, M., ... Iapichino, G. (2017). Melatonin pharmacological blood levels increase total antioxidant capacity in critically ill patients. International Journal of Molecular Sciences, 18(4), [759]. https://doi.org/10.3390/ijms18040759

Melatonin pharmacological blood levels increase total antioxidant capacity in critically ill patients. / Mistraletti, Giovanni; Paroni, Rita; Umbrello, Michele; D’Amato, Lara; Sabbatini, Giovanni; Taverna, Martina; Formenti, Paolo; Finati, Elena; Favero, Gaia; Bonomini, Francesca; Rezzani, Rita; Reiter, Russel J; Iapichino, Gaetano.

In: International Journal of Molecular Sciences, Vol. 18, No. 4, 759, 01.04.2017.

Research output: Contribution to journalArticle

Mistraletti, G, Paroni, R, Umbrello, M, D’Amato, L, Sabbatini, G, Taverna, M, Formenti, P, Finati, E, Favero, G, Bonomini, F, Rezzani, R, Reiter, RJ & Iapichino, G 2017, 'Melatonin pharmacological blood levels increase total antioxidant capacity in critically ill patients', International Journal of Molecular Sciences, vol. 18, no. 4, 759. https://doi.org/10.3390/ijms18040759
Mistraletti, Giovanni ; Paroni, Rita ; Umbrello, Michele ; D’Amato, Lara ; Sabbatini, Giovanni ; Taverna, Martina ; Formenti, Paolo ; Finati, Elena ; Favero, Gaia ; Bonomini, Francesca ; Rezzani, Rita ; Reiter, Russel J ; Iapichino, Gaetano. / Melatonin pharmacological blood levels increase total antioxidant capacity in critically ill patients. In: International Journal of Molecular Sciences. 2017 ; Vol. 18, No. 4.
@article{325b0db6db6e460a957f53c21e4b0f80,
title = "Melatonin pharmacological blood levels increase total antioxidant capacity in critically ill patients",
abstract = "In this study, the aim was to test the biochemical effects of melatonin supplementation in Intensive Care Unit (ICU) patients, since their blood levels are decreased. Sixty-four patients were enrolled in the study. From the evening of the 3rd ICU day, patients were randomized to receive oral melatonin (3 mg, group M) or placebo (group P) twice daily, at 20:00 and 24:00, until discharged. Blood was taken (at 00:00 and 14:00), on the 3rd ICU day to assess basal nocturnal melatonin values, and then during the treatment period on the 4th and 8th ICU days. Melatonin, total antioxidant capacity, and oxidative stress were evaluated in serum. Melatonin circadian rhythm before treatment was similar in the two groups, with a partial preservation of the cycle. Four hours from the 1st administration (4th ICU day, 00:00), melatonin levels increased to 2514 (982.3; 7148) pg·mL−1 in group M vs. 20.3 (14.7; 62.3) pg·mL−1 in group P (p < 0.001). After five treatment days (8th ICU day), melatonin absorption showed a repetitive trend in group M, while in group P nocturnal secretion (00:00) was impaired: 20 (11.5; 34.5) pg·mL−1 vs. 33.8 (25.0; 62.2) on the 3rd day (p = 0.029). Immediately from the beginning of treatment, the total antioxidant capacity was significantly higher in melatonin treated subjects at 00:00; a significant correlation was found between total antioxidant capacity and blood melatonin values (ρ = 0.328; p < 0.001). The proposed enteral administration protocol was adequate, even in the early phase, to enhance melatonin blood levels and to protect the patients from oxidative stress. The antioxidant effect of melatonin could play a meaningful role in the care and well-being of these patients.",
keywords = "Antioxidants, Critical illness, Dietary supplements, Melatonin, Oxidative stress",
author = "Giovanni Mistraletti and Rita Paroni and Michele Umbrello and Lara D’Amato and Giovanni Sabbatini and Martina Taverna and Paolo Formenti and Elena Finati and Gaia Favero and Francesca Bonomini and Rita Rezzani and Reiter, {Russel J} and Gaetano Iapichino",
year = "2017",
month = "4",
day = "1",
doi = "10.3390/ijms18040759",
language = "English (US)",
volume = "18",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - Melatonin pharmacological blood levels increase total antioxidant capacity in critically ill patients

AU - Mistraletti, Giovanni

AU - Paroni, Rita

AU - Umbrello, Michele

AU - D’Amato, Lara

AU - Sabbatini, Giovanni

AU - Taverna, Martina

AU - Formenti, Paolo

AU - Finati, Elena

AU - Favero, Gaia

AU - Bonomini, Francesca

AU - Rezzani, Rita

AU - Reiter, Russel J

AU - Iapichino, Gaetano

PY - 2017/4/1

Y1 - 2017/4/1

N2 - In this study, the aim was to test the biochemical effects of melatonin supplementation in Intensive Care Unit (ICU) patients, since their blood levels are decreased. Sixty-four patients were enrolled in the study. From the evening of the 3rd ICU day, patients were randomized to receive oral melatonin (3 mg, group M) or placebo (group P) twice daily, at 20:00 and 24:00, until discharged. Blood was taken (at 00:00 and 14:00), on the 3rd ICU day to assess basal nocturnal melatonin values, and then during the treatment period on the 4th and 8th ICU days. Melatonin, total antioxidant capacity, and oxidative stress were evaluated in serum. Melatonin circadian rhythm before treatment was similar in the two groups, with a partial preservation of the cycle. Four hours from the 1st administration (4th ICU day, 00:00), melatonin levels increased to 2514 (982.3; 7148) pg·mL−1 in group M vs. 20.3 (14.7; 62.3) pg·mL−1 in group P (p < 0.001). After five treatment days (8th ICU day), melatonin absorption showed a repetitive trend in group M, while in group P nocturnal secretion (00:00) was impaired: 20 (11.5; 34.5) pg·mL−1 vs. 33.8 (25.0; 62.2) on the 3rd day (p = 0.029). Immediately from the beginning of treatment, the total antioxidant capacity was significantly higher in melatonin treated subjects at 00:00; a significant correlation was found between total antioxidant capacity and blood melatonin values (ρ = 0.328; p < 0.001). The proposed enteral administration protocol was adequate, even in the early phase, to enhance melatonin blood levels and to protect the patients from oxidative stress. The antioxidant effect of melatonin could play a meaningful role in the care and well-being of these patients.

AB - In this study, the aim was to test the biochemical effects of melatonin supplementation in Intensive Care Unit (ICU) patients, since their blood levels are decreased. Sixty-four patients were enrolled in the study. From the evening of the 3rd ICU day, patients were randomized to receive oral melatonin (3 mg, group M) or placebo (group P) twice daily, at 20:00 and 24:00, until discharged. Blood was taken (at 00:00 and 14:00), on the 3rd ICU day to assess basal nocturnal melatonin values, and then during the treatment period on the 4th and 8th ICU days. Melatonin, total antioxidant capacity, and oxidative stress were evaluated in serum. Melatonin circadian rhythm before treatment was similar in the two groups, with a partial preservation of the cycle. Four hours from the 1st administration (4th ICU day, 00:00), melatonin levels increased to 2514 (982.3; 7148) pg·mL−1 in group M vs. 20.3 (14.7; 62.3) pg·mL−1 in group P (p < 0.001). After five treatment days (8th ICU day), melatonin absorption showed a repetitive trend in group M, while in group P nocturnal secretion (00:00) was impaired: 20 (11.5; 34.5) pg·mL−1 vs. 33.8 (25.0; 62.2) on the 3rd day (p = 0.029). Immediately from the beginning of treatment, the total antioxidant capacity was significantly higher in melatonin treated subjects at 00:00; a significant correlation was found between total antioxidant capacity and blood melatonin values (ρ = 0.328; p < 0.001). The proposed enteral administration protocol was adequate, even in the early phase, to enhance melatonin blood levels and to protect the patients from oxidative stress. The antioxidant effect of melatonin could play a meaningful role in the care and well-being of these patients.

KW - Antioxidants

KW - Critical illness

KW - Dietary supplements

KW - Melatonin

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=85017192116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017192116&partnerID=8YFLogxK

U2 - 10.3390/ijms18040759

DO - 10.3390/ijms18040759

M3 - Article

C2 - 28368352

AN - SCOPUS:85017192116

VL - 18

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 4

M1 - 759

ER -